CFD
REGN icon

Creative Financial Designs’s Regeneron Pharmaceuticals REGN Stock Holding History

Creative Financial Designs’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5K Sell
28
-1
-3% -$681 ﹤0.01% 1351
2026
Q1 		$22.4K Hold
29
– – ﹤0.01% 1168
2025
Q4 		$22.4K Buy
29
+1
+4% +$679 ﹤0.01% 1121
2025
Q3 		$15.7K Sell
28
-203
-88% -$115K ﹤0.01% 1221
2025
Q2 		$121K Buy
231
+11
+5% +$6.14K 0.01% 622
2025
Q1 		$139K Buy
220
+19
+9% +$13.1K 0.01% 536
2024
Q4 		$143K Buy
201
+27
+16% +$22.7K 0.01% 524
2024
Q3 		$182K Sell
174
-4
-2% -$4.45K 0.02% 471
2024
Q2 		$187K Buy
178
+3
+2% +$2.91K 0.02% 446
2024
Q1 		$168K Sell
175
-8
-4% -$7.61K 0.02% 460
2023
Q4 		$160K Buy
183
+1
+0.5% +$823 0.02% 440
2023
Q3 		$149K Hold
182
– – 0.02% 404
2023
Q2 		$130K Sell
182
-4
-2% -$3.08K 0.02% 426
2023
Q1 		$152K Sell
186
-11
-6% -$8.3K 0.02% 377
2022
Q4 		$142K Hold
197
– – 0.02% 381
2022
Q3 		$136K Buy
197
+3
+2% +$1.89K 0.02% 364
2022
Q2 		$115K Sell
194
-5
-3% -$3.25K 0.02% 403
2022
Q1 		$139K Sell
199
-2
-1% -$1.26K 0.02% 377
2021
Q4 		$127K Buy
201
+176
+704% +$108K 0.02% 394
2021
Q3 		$15K Hold
25
– – ﹤0.01% 932
2021
Q2 		$14K Hold
25
– – ﹤0.01% 949
2021
Q1 		$12K Buy
25
+12
+92% +$5.84K ﹤0.01% 903
2020
Q4 		$6K Buy
13
+5
+63% +$2.7K ﹤0.01% 956
2020
Q3 		$4K Buy
+8
New +$4.85K ﹤0.01% 988
2017
Q4 		– Sell
-28
Closed -$11.3K – 763
2017
Q3 		$12K Hold
28
– – 0.01% 397
2017
Q2 		$14K Sell
28
-36
-56% -$15.8K 0.01% 375
2017
Q1 		$25K Sell
64
-533
-89% -$198K 0.02% 298
2016
Q4 		$219K Buy
+597
New +$227K 0.18% 112

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Creative Financial Designs's REGN Position: Q2 2026 in Review

Creative Financial Designs reduced its Regeneron Pharmaceuticals (REGN) stake by 3.4% in Q2 2026, selling an estimated $681 and leaving 28 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Creative Financial Designs first reported a position in REGN in Q4 2016 and has held it in 28 quarters since. The position peaked at $219K in Q4 2016. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Creative Financial Designs held 28 shares of Regeneron Pharmaceuticals worth $17.5K as of Q2 2026.
  • Creative Financial Designs sold 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1351 holding.
  • Creative Financial Designs first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 28 quarters since.
  • Creative Financial Designs's Regeneron Pharmaceuticals position peaked at $219K in Q4 2016.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.